“I took charge of my own and my babies' gut health, because I knew it was fundamental for their lifelong health.”
Between her two kids, founder and CEO of Tiny Health, Cheryl Sew Hoy, had two radically different birth experiences.
One presented breech and was born by C-section. Whereas the younger sibling was born at home and with the support of a midwife. Guess which baby battled eczema and food allergies?
In spite of exclusive breastfeeding and homemade kefir, Cheryl’s daughter - her first baby - had mild eczema and needed to work through a sesame allergy after starting solids.
Our Scientific and Medical Advisors
Our mission is to improve health outcomes of future generations through evidence-based insights
Tiny Health is the first research-backed platform to profile a baby’s microbes during their first 1,000 days, which begin at conception. This includes the mother’s microbiome within 9 months of pregnancy and the baby’s microbiome within their first two years. Catching patterns of gut dysbiosis unique to pregnancy and infancy can give parents the opportunity to protect against immune-mediated diseases that are programmed during this window of development. Research shows that these imbalances may lead to chronic conditions such as eczema, food allergies, asthma, type I diabetes, and obesity later in life.
Using at-home test kits, next generation sequencing, a proprietary knowledge base, and AI technology, Tiny Health provides key insights during this critical period as the microbiome rapidly takes shape and sets the trajectory for lifelong health. This helps us to generate personalized, actionable recommendations and early interventions that give each baby the best possible start in life.
We will be launching in the fall but allowing early users to get access to our
vaginal and gut microbiome tests.